SREBF1 and breast cancer: The results demonstrated that RARRES2 mediates lipid metabolism reprogramming by modulating the PTEN-mTOR-SREBP1 signaling pathway, leading to increased glycerophospholipid levels and decreased triglyceride levels and promoting the proliferation of breast cancer cells within the brain microenvironment [31].